TrueCAGR

Tata Consultancy Services Ltd.

NSE: TCSBSE: 532540ISIN INE467B01029Face value ₹1standalone
₹2,079
+2.13% · 2026-10-01 · 52-wk ₹1,983–₹3,325
Financials to FY2026 · 8 years of history · prices to 2026-10-01consolidatedstandalone
Section 02 · Synthesis

What stands out?

The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.

StrengthConcernWatchContext
StrengthTalking point

More profitable than peers

ROE of 48.4% is well above the computers software and consulting median of 21.3%.

Importance 60 / 95 · profitability

WatchTalking point

Growth slowing

Revenue growth has slowed for 3 consecutive years, from 17.6% to 4.6%.

Importance 57 / 95 · growth

Context

Lower P/E than peers

Trades at 15.04× earnings — 33% below the computers software and consulting median of 22.52×.

Importance 48 / 95 · valuation

Section 03 · The company

Who is this company?

Classified by the exchange under Information Technology › Information Technology › IT - Software › Computers - Software & Consulting.

Market cap
₹7.53 L cr
FY2026 revenue
₹2,20,938 cr
FY2026 net profit
₹49,096 cr
Net worth
₹84,676 cr
Total debt
₹0 crnet cash
EPS (basic)
₹135.70
Listed
NSE · BSE
Reporting
Ind-ASApr–Mar

Peer set used on this page: 9 computers - software & consulting.

Section 04 · Business performance

Is the business growing?

Revenue & net profit — FY19 to FY26₹ crore · consolidated
₹'000 cr07515022530002550REVENUENET PROFIT1.23L30,065FY191.31L33,260FY201.36L30,960FY211.60L38,187FY221.90L39,106FY232.02L43,559FY242.15L48,057FY252.21L49,096FY26
RevenueNet profit
Watch

Revenue growth has slowed for 3 consecutive years, from 17.6% to 4.6%.

Rule GROWTH_DECELERATING

Revenue growth per year
+8.7%over 7 years
Revenue growth
+2.8%vs last year
Net profit growth
+2.2%vs last year
Change in net profit since FY19
+63%

Revenue has compounded at 9.0% a year over 7 years (₹1,46,463 → ₹2,67,021) — steady rather than rapid.

Section 05 · Recent activity

What changed recently?

Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.

Strength

Q1 FY27 revenue was ₹72,275 cr, up 13.9% from ₹63,437 cr in Q1 FY26 a year earlier.

Rule QTR_REVENUE_GROWTH_YOY

Watch

Q1 FY27 interest (finance cost) was ₹273 cr, up 40.0% from ₹195 cr a year earlier.

Rule QTR_INTEREST_EXPENSE_CHANGE_YOY

Strength

Q1 FY27 revenue of ₹72,275 cr is the highest of the 16 quarters on record for this company.

Rule QTR_REVENUE_AT_RECORD

A. Quarterly results

Latest quarters — Q2 '25 to Q1 '27₹ crore · consolidated
₹'000 cr02040608001020REVENUENET PROFIT64k11,955Q2 '2564k12,444Q3 '2564k12,293Q4 '2563k12,819Q1 '2666k12,131Q2 '2667k10,720Q3 '2671k13,784Q4 '2672k13,420Q1 '27
RevenueNet profit
QuarterRevenueYoYNet profitYoYNet margin
Q2 FY2564,259—11,955—18.6%
Q3 FY2563,973+5.6%12,444+12.1%19.5%
Q4 FY2564,479+5.3%12,293−1.7%19.1%
Q1 FY2663,437+1.3%12,819+5.9%20.2%
Q2 FY2665,799+2.4%12,131+1.5%18.4%
Q3 FY2667,087+4.9%10,720−13.9%16.0%
Q4 FY2670,698+9.6%13,784+12.1%19.5%
Q1 FY2772,275+13.9%13,420+4.7%18.6%

B. TTM snapshot

Trailing twelve months to 30 Jun 2026 · sum of the last 4 contiguous quarters

Revenue
₹2,75,859 crTTM
EBITDA
₹78,389 crTTM
EBIT
₹72,951 crTTM
PBT
₹66,452 crTTM
Net profit
₹50,055 crTTM

C. Corporate actions

14 Oct 2026DividendInterim Dividend
15 Jul 2026DividendInterim Dividend - Rs. - 12.0000 — ₹12.00/share
25 May 2026DividendFinal Dividend - Rs. - 31.0000 — ₹31.00/share
16 Jan 2026DividendInterim Dividend - Rs. - 11.0000 — ₹11.00/share
16 Jan 2026DividendSpecial Dividend - Rs. - 46.0000 — ₹46.00/share
15 Oct 2025DividendInterim Dividend - Rs. - 11.0000 — ₹11.00/share
16 Jul 2025DividendInterim Dividend - Rs. - 11.0000 — ₹11.00/share
4 Jun 2025DividendFinal Dividend - Rs. - 30.0000 — ₹30.00/share
17 Jan 2025DividendSpecial Dividend - Rs. - 66.0000 — ₹66.00/share
17 Jan 2025DividendInterim Dividend - Rs. - 10.0000 — ₹10.00/share
18 Oct 2024DividendInterim Dividend - Rs. - 10.0000 — ₹10.00/share
19 Jul 2024DividendInterim Dividend - Rs. - 10.0000 — ₹10.00/share
16 May 2024DividendFinal Dividend - Rs. - 28.0000 — ₹28.00/share
19 Jan 2024DividendSpecial Dividend - Rs. - 18.0000 — ₹18.00/share
19 Jan 2024DividendInterim Dividend - Rs. - 9.0000 — ₹9.00/share
24 Nov 2023BuybackBuy Back of Shares
19 Oct 2023DividendInterim Dividend - Rs. - 9.0000 — ₹9.00/share
20 Jul 2023DividendInterim Dividend - Rs. - 9.0000 — ₹9.00/share
15 Jun 2023DividendFinal Dividend - Rs. - 24.0000 — ₹24.00/share
16 Jan 2023DividendSpecial Dividend - Rs. - 67.0000 — ₹67.00/share
16 Jan 2023DividendInterim Dividend - Rs. - 8.0000 — ₹8.00/share
17 Oct 2022DividendInterim Dividend - Rs. - 8.0000 — ₹8.00/share
14 Jul 2022DividendInterim Dividend - Rs. - 8.0000 — ₹8.00/share
25 May 2022DividendFinal Dividend - Rs. - 22.0000 — ₹22.00/share
22 Feb 2022BuybackBuy Back of Shares
Section 06 · Business performance

Is it becoming more profitable?

Margins — FY19 to FY26% of revenue · consolidated
0%5%10%15%20%25%30%35%32.7%21.3%FY19FY20FY21FY22FY23FY24FY25FY26
EBITDA marginNet margin
Strength

ROE of 48.4% is well above the computers software and consulting median of 21.3%.

Rule ROE_ABOVE_PEER_MEDIAN

EBITDA margin now
32.7%
8-year range
29.6–34.6%
ROE FY2026
61.3%
ROCE FY2026
84.8%

ROE declined from 52.2% to 48.4% year on year.

Section 07 · Financial health

Is financial health improving?

Net worth — FY19 to FY26₹ crore · consolidated
₹'000 crtotal debt ≈ ₹0 across the history030609079kFY1974kFY2075kFY2177kFY2275kFY2372kFY2476kFY2585kFY26
Net worth (shareholders' funds)
Strength

Free cash flow has been positive in 6 of the last 6 years.

Rule FCF_CONSISTENTLY_POSITIVE

Operating cash flow vs net profit₹ crore · FY21–FY26
0k17k33k50k34k31kFY2136k38kFY2237k39kFY2339k44kFY2441k48kFY2546k49kFY26
Operating cash flowNet profit
Total debt
₹0 crnet cash
Operating cash flow ÷ net profit
0.93×FY2026
Free cash flow
₹42,576 cr
Current ratio
2.01×
Section 08 · Relative position

How does it compare with peers?

Ranked against 9 computers - software & consulting (FY2026, consolidated).

Revenue growth

TCS · 8th of 9 · set median 11.2%

COFORGE36.1%PERSISTENT23.5%MPHASIS11.6%LTM11.3%HCLTECH11.2%INFY9.6%TECHM7.2%TCS4.6%WIPRO4.0%

EBITDA margin

TCS · 1st of 9 · set median 20.8%

TCS28.8%INFY26.1%WIPRO23.4%HCLTECH21.7%MPHASIS20.8%LTM20.4%PERSISTENT20.2%COFORGE18.3%TECHM16.0%

Return on equity

TCS · 1st of 9 · set median 21.3%

TCS48.4%INFY31.1%PERSISTENT26.3%HCLTECH23.0%LTM21.3%COFORGE19.4%MPHASIS18.3%TECHM16.6%WIPRO15.5%

P/E ratio

TCS · 3rd of 9 · set median 22.5×

WIPRO12.6×INFY13.8×TCS15.0×HCLTECH19.4×MPHASIS22.5×LTM22.9×TECHM26.4×COFORGE31.9×PERSISTENT43.9×
Context

Trades at 15.04× earnings — 33% below the computers software and consulting median of 22.52×.

Rule PE_BELOW_PEERS

P / E
15.0×TTM to Jun 26
P / B
6.9×latest book
P / S
2.7×TTM sales
Earnings yield
6.7%TTM to Jun 26

On the trailing twelve months. Last full year: P/E 15.2× · P/S 2.8× · ROE 48.4%.

Section 09 · The stock

How has the stock performed?

Adjusted close — 2020-01 to 2026-10₹ per share · split / bonus adjusted
0k4k₹2,0792020202120222023202420252026

Long-term price performance is shown above.

1-year return
−28.6%
3-year return
−41.1%
5-year return
−44.3%
From 52-wk high
−37.5%
Section 10 · Technical data

What does the technical data say?

Price-action indicators as of 2026-10-01. Secondary to the fundamentals above — included for timing context, not as a signal.

vs 50-day avg
Below₹2,280
vs 200-day avg
Below₹2,524
RSI (14)
36.9neutral
MACD histogram
-10.2
From 52-wk high
−37.5%
From 52-wk low
+4.9%
30-day volatility
25.6%ann.
6-month return
−13.0%
RSI (14) · 0–10036.9 — neutral
0305070100OVERSOLDOVERBOUGHT36.9
Section 11 · Open questions

What should I investigate further?

Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.

  • Watch
    Growth slowing
    Revenue growth has slowed for 3 consecutive years, from 17.6% to 4.6%.
    GROWTH_DECELERATING · conviction 57
  • Concern
    Returns declining
    ROE declined from 52.2% to 48.4% year on year.
    ROE_DETERIORATED_YOY · conviction 44
  • Cash-flow-statement facts are unavailable for FY2019, FY2020 — those filings predate SEBI's Cash Flow Statement disclosure requirement. All other loaded years carry full P&L, balance sheet and cash-flow data.
Section 12 · Reference

The numbers

The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.

Income & balance sheet — ₹ crore, consolidated
MetricFY19FY20FY21FY22FY23FY24FY25FY26
Revenue1,23,1701,31,3061,35,9631,60,3411,90,3542,02,3592,14,8532,20,938
Total income1,30,7971,39,3881,41,3631,67,8271,95,6822,09,6322,24,4952,30,974
EBITDA42,59145,43545,71053,73156,32563,12067,57172,285
Profit before tax40,70541,99140,90249,72351,69057,60262,64862,806
Net profit30,06533,26030,96038,18739,10643,55948,05749,096
EPS (₹)79.388.682.8103.2106.9119.4132.8135.7
Net worth78,89874,36874,79477,17374,53872,12075,61784,676
Total debt330000000
Operating cash flow——33,82236,12737,02939,14240,81645,597
Free cash flow——31,75134,00935,01737,43638,45142,576
Key ratios — consolidated
RatioFY19FY20FY21FY22FY23FY24FY25FY26
Growth
Revenue growth YoY—6.63.517.918.76.36.22.8
Profit growth YoY—10.6-6.923.32.411.410.32.2
Profitability
EBITDA margin %34.634.633.633.529.631.231.432.7
Net margin %23.023.921.922.820.020.821.421.3
Return on equity %38.143.441.550.351.659.465.161.3
Return on capital %51.855.857.266.169.180.885.884.8
Leverage & cash
Debt to equity0.000.000.000.000.000.000.000.00
Cash flow ÷ profit——1.090.950.950.900.850.93
Current ratio4.183.302.922.492.362.202.102.01
Financials: BSE Integrated Filing inline XBRL (SEBI taxonomy), normalised to standard metric keys. Prices: NSE end-of-day, raw OHLC preserved; a corporate-action factor produces the adjusted series. The insight engine writes factual observations from fixed rules — it does not make recommendations. Not investment advice.